• Joint Effort to Aid Diabetes Patients • MedicalExpo e-Magazine
    The Smart Magazine About Medical Technology Innovations

    #30- Innovative Labs

    Joint Effort to Aid Diabetes Patients

    /

    A recently-announced partnership between two US firms is designed to further artificial pancreas research. Maryland-based Senseonics is developing a subcutaneous continuous glucose monitor (CGM) the size of a pill, part of its Eversense System. It automatically transmits readings to a mobile app for up to 90 days.
    The agreement aims to integrate monitor data with the inControl diabetes management software from TypeZero Technologies, located in neighboring Virginia. The readings will enable TypeZero’s artificial pancreas algorithms to control a user’s insulin pump. The combination also can indicate dosage for insulin pen users. Other advantages include the sensor’s small size and life expectancy, far longer than the five to seven days of existing systems.
    TypeZero CEO Chad Rogers explains in a press release that “integrating our inControl platform with the reliable and durable Eversense CGM System…could give patients yet another tool for managing their health and simplifying their lives.”


    About the Author

    Michael Halpern is a US-born and bred writer with experience in radio. He has lived in southern France for 15 years.

    Related Posts

    Cardiac pacemakers and other implantable medical devices can improve, prolong and even save human...

    Researchers at Northwestern University in Chicago used 3D printing to create a bioprosthetic mouse...

    Protective equipment manufacturer Noroit won honors in the ergonomics/design/comfort category at...

    Style Switcher

    Highlight Color:

                   

    Backgrounds:

                        

    You can also set your own colors or background from the Admin Panel.